ROYAL BANK OF CANADA - SILVERBACK THERAPEUTICS INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15,000
-37.5%
3,842
+6.9%
0.00%
Q2 2023$24,0003,594
+71780.0%
0.00%
Q1 2023$050.0%0.00%
Q4 2022$0
-100.0%
5
-99.6%
0.00%
Q1 2022$4,000
-85.7%
1,260
-69.4%
0.00%
Q4 2021$28,000
+21.7%
4,121
+76.1%
0.00%
Q3 2021$23,000
-25.8%
2,340
+135.6%
0.00%
Q2 2021$31,000
-39.2%
993
-14.2%
0.00%
Q1 2021$51,0001,1580.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Nextech Invest Ltd. 1,910,029$12,721,0003.35%
Orbimed Advisors 8,740,887$58,214,0000.75%
Nantahala Capital Management 1,006,462$6,703,0000.24%
EcoR1 Capital, LLC 1,060,010$7,060,0000.22%
Prosight Management, LP 53,815$358,0000.21%
RA Capital Management 1,742,186$11,603,0000.20%
Endurant Capital Management LP 84,295$561,0000.14%
HighVista Strategies LLC 22,434$149,0000.12%
XTX Topco Ltd 18,816$125,0000.07%
WASATCH ADVISORS LP 1,773,690$11,813,0000.05%
View complete list of SILVERBACK THERAPEUTICS INC shareholders